openPR Logo
Press release

Forecast for the AI In Clinical Trials market indicates exponential growth with a comprehensive SWOT analysis from 2023 to 2030.| Intel, The International Business Machines Corporation (IBM), Koninklijke Philips N.V., ConcertAI

08-31-2023 03:33 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Factual Market Research

AI In Clinical Trials market

AI In Clinical Trials market

AI In Clinical Trialsย Report Coverage: Key Growth Challenges and Factors, regional Outlook and segmentation trends and opportunities in the top Industries Analysis of the competition, Market forecasting and sizing

The report's thorough analysis explains how numerous aspects contribute to the growth of the AI In Clinical Trials Market. This study demonstrates the value of in-depth research and its significant impact on the information readers receive. Additionally, the effect of the AI In Clinical Trials market is considered in this analysis. It precisely evaluates the anticipated market fluctuations throughout the forecast period, divided into distinct sub-regions and nations/regions. This research section includes data on profit prospects and market share in each country and subregion.

๐Ž๐ฏ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ:

Artificial intelligence (AI) in clinical trials refers to using AI technology and methodologies in the organization, planning, execution, and analysis of clinical studies. Clinical trials are careful research studies that assess the efficacy and security of medical interventions in patients, such as novel medications, devices, or treatment strategies.

Explore the comprehensive Table Of Contents, tables, and charts spread across pages, offering exclusive data, insights, vital statistics, trends, and a deep dive into this specialized industry.

๐“๐จ ๐ซ๐ž๐ฆ๐š๐ข๐ง '๐š๐ก๐ž๐š๐' ๐จ๐Ÿ ๐ฒ๐จ๐ฎ๐ซ ๐œ๐จ๐ฆ๐ฉ๐ž๐ญ๐ข๐ญ๐จ๐ซ๐ฌ, ๐ซ๐ž๐ช๐ฎ๐ž๐ฌ๐ญ ๐š ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐œ๐จ๐ฉ๐ฒ ๐š๐ญ: https://www.factualmarketresearch.com/Custom-Request-for-sample/AI-In-Clinical-Trials-Market

๐€๐๐ฏ๐š๐ง๐ญ๐š๐ ๐ž๐ฌ ๐จ๐Ÿ ๐ซ๐ž๐ช๐ฎ๐ž๐ฌ๐ญ๐ข๐ง๐  ๐š ๐’๐š๐ฆ๐ฉ๐ฅ๐ž ๐‚๐จ๐ฉ๐ฒ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ:

โžฅ The Report is completely customizable and can be redesigned as per your specific requirements.
โžฅย You can option to purchase certain chapter/sections of the complete report.
โžฅย You can also purchase just the qualitative or quantitative information as per your choice and need.

๐–๐ก๐จ ๐š๐ซ๐ž ๐ญ๐ก๐ž ๐Œ๐š๐ฃ๐จ๐ซ AI In Clinical Trials ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐Š๐ž๐ฒ ๐๐ฅ๐š๐ฒ๐ž๐ซ๐ฌ?

โ—ˆ Intel
โ—ˆ The International Business Machines Corporation (IBM)
โ—ˆ Koninklijke Philips N.V.
โ—ˆ ConcertAI
โ—ˆ Saama Technologies LLC
โ—ˆ Samaa Technologies
โ—ˆ Owkin Inc.
โ—ˆ Numerate
โ—ˆ Neuroute
โ—ˆ AiCure
โ—ˆ Ardigen
โ—ˆ Unlearn AI
โ—ˆ PathAI
โ—ˆ Exscentia
โ—ˆ Aitia Infotech Pvt Ltd.
โ—ˆ Euretos
โ—ˆ VeriSIM Life
โ—ˆ Envisagenics
โ—ˆ NURITAs
โ—ˆ BioSymetrics
โ—ˆ BioAge Labs Inc
โ—ˆ Trials.AI
โ—ˆ Pharmaseal
โ—ˆ Caylx
โ—ˆ IQVIA.

๐…๐ž๐ž๐ฅ ๐…๐ซ๐ž๐ž ๐ญ๐จ ๐‚๐จ๐ง๐ญ๐š๐œ๐ญ ๐”๐ฌ ๐Ÿ๐จ๐ซ ๐š๐ง๐ฒ ๐œ๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ: https://www.factualmarketresearch.com/Custom-Request-for-customization/AI-In-Clinical-Trials-Market

๐’๐ž๐ ๐ฆ๐ž๐ง๐ญ๐š๐ญ๐ข๐จ๐ง ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐จ๐Ÿ ๐ญ๐ก๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ

The market is segmented on the basis of the product, type, end users, and application. Segmentation is considered to be the most vital part of the report which helps the reader to understand the market in prรฉcised way.

By Offering:
โ—ˆ Software
โ—ˆ Services

By Process:
โ—ˆ Trial Design
โ—ˆ Patient Selection
โ—ˆ Site Selection
โ—ˆ Patient Monitoring

By Technology:
โ—ˆ Machine Learning
โ—ˆ Deep Learning
โ—ˆ Supervised Learning
โ—ˆ Other Technologies

By Application:
โ—ˆ Oncology
โ—ˆ Neurological Diseases And Condition
โ—ˆ Cardiovascular Diseases
โ—ˆ Metabolic Diseases
โ—ˆ Infectious Diseases
โ—ˆ Immunology diseases
โ—ˆ Other Applications

By End-User:
โ—ˆ Pharmaceuticals And Biotechnology Companies
โ—ˆ Contract Research Organizations
โ—ˆ Other End-Users

๐ˆ๐Ÿ ๐ฒ๐จ๐ฎ ๐ก๐š๐ฏ๐ž ๐š๐ง๐ฒ ๐ช๐ฎ๐ž๐ซ๐ข๐ž๐ฌ ๐ซ๐ž๐ฅ๐š๐ญ๐ž๐ ๐ญ๐จ ๐ญ๐ก๐ž ๐ญ๐ก๐ข๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ซ๐ž๐ฉ๐จ๐ซ๐ญ, ๐ฉ๐ฅ๐ž๐š๐ฌ๐ž ๐ ๐ž๐ญ ๐ข๐ง ๐ญ๐จ๐ฎ๐œ๐ก ๐ฐ๐ข๐ญ๐ก ๐จ๐ฎ๐ซ ๐ž๐ฑ๐ฉ๐ž๐ซ๐ญ ๐š๐ญ: https://www.factualmarketresearch.com/Custom-inquiry-buying/AI-In-Clinical-Trials-Market

Overall, the research offers organizations a competitive advantage over competing businesses and guarantees long-term success in the worldwide AI In Clinical Trials industry. The report's findings, facts, and information have been verified and confirmed with reliable sources. For an in-depth analysis of the worldwide AI In Clinical Trials market, the analysts who composed the piece utilized a distinctive and exceptional research and analysis approach.

๐‘๐ž๐ ๐ข๐จ๐ง๐š๐ฅ ๐€๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ

ยป North America (United States, Canada)

ยปEurope (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)

ยปAsia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)

ยปLatin America (Brazil, Mexico, Argentina)

ยปMiddle East and Africa (Saudi Arabia, UAE, Egypt, South Africa)

๐“๐ก๐ž ๐Ÿ๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐  ๐ฒ๐ž๐š๐ซ๐ฌ ๐ฐ๐ž๐ซ๐ž ๐ญ๐š๐ค๐ž๐ง ๐ข๐ง๐ญ๐จ ๐œ๐จ๐ง๐ฌ๐ข๐๐ž๐ซ๐š๐ญ๐ข๐จ๐ง ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐š๐ง๐š๐ฅ๐ฒ๐ฌ๐ข๐ฌ ๐ญ๐จ ๐ž๐ฌ๐ญ๐ข๐ฆ๐š๐ญ๐ž ๐ญ๐ก๐ž ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ฌ๐ข๐ณ๐ž ๐จ๐Ÿ ๐ญ๐ก๐ž AI In Clinical Trials ๐Œ๐š๐ซ๐ค๐ž๐ญ:

History Year: 2019-2023
Base Year: 2023
Estimated Year: 2023
Forecast Year: 2023 to 2030

๐๐ฎ๐ซ๐œ๐ก๐š๐ฌ๐ž ๐ญ๐ก๐ข๐ฌ ๐๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐Œ๐š๐ซ๐ค๐ž๐ญ ๐‘๐ž๐ฉ๐จ๐ซ๐ญ ๐ฐ๐ข๐ญ๐ก ๐Ÿ๐ฅ๐š๐ญ ๐Ÿ๐Ÿ“% ๐๐ข๐ฌ๐œ๐จ๐ฎ๐ง๐ญ ๐š๐ญ: https://www.factualmarketresearch.com/Custom-checkout/AI-In-Clinical-Trials-Market

For the industry's stakeholders, including manufacturers, partners, end users, etc., the research gives answers to a number of crucial questions that are crucial for helping them plan investments and take advantage of market opportunities.ย 

Key Pointers That the Report Acknowledges:

โœฆ Market size and growth rate for the time frame of assessment.
โœฆ Leading market providers and dealers.
โœฆ thorough SWOT analysis of every organization.
โœฆ in-depth Regional PEST analysis.
โœฆ Opportunities and challenges that the current vendors in the AI In Clinical Trials industry must deal with.
โœฆ Leading players take on strategic objectives.

Contact Us
Factual Market Research
Email id: sales@factualmarketresearch.com
Ph.: US +18007743961 | UK +448081897087 | APAC +919717322206
Website: www.factualmarketresearch.com

About Us
We at Factual Market Research are always looking for ways to do better. We are committed to offering companies in-depth information that will aid in planning precise and successful growth strategies for our customers.
We are aware of the quantity and quality of the information flowing. We can categorize and rectify the data required for insight through a thorough and synchronized analytical effort. By offering sensitive data collection and analysis on-site, we assume responsibility for providing our respected clients with detailed and exhaustive research and data gathering.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Forecast for the AI In Clinical Trials market indicates exponential growth with a comprehensive SWOT analysis from 2023 to 2030.| Intel, The International Business Machines Corporation (IBM), Koninklijke Philips N.V., ConcertAI here

News-ID: 3190869 • Views: โ€ฆ

More Releases from Factual Market Research

Vertical Lights Market: Analysis and Predictions of Global Trends from 2023 to 2030 by the Top Key Players| Artemide, Crenshaw, Maxim Lighting, GriplockSystems
Vertical Lights Market: Analysis and Predictions of Global Trends from 2023 to 2 โ€ฆ
The Factual Market Research offers the [2023-2030] Vertical Lights contains a SWOT analysis and a Porter's five forces analysis, which aid in determining the market's precise path. These market measurement methods aid in the identification of market drivers, restraints, weaknesses, market opportunities, and threats. The research report includes global market numbers as well as regional market and segment figures. The analysts evaluated the categories using a top-down and bottom-up approachโ€ฆ
Forecast for the Circular Polarizer market indicates exponential growth with a comprehensive SWOT analysis from 2023 to 2030.| LG Chem Ltd., Nitto Denko Corporation, Sumitomo Chemical, BenQ Materials (BQM)
Forecast for the Circular Polarizer market indicates exponential growth with a c โ€ฆ
The Factual Market Research offers the [2023-2030] Circular Polarizer contains a SWOT analysis and a Porter's five forces analysis, which aid in determining the market's precise path. These market measurement methods aid in the identification of market drivers, restraints, weaknesses, market opportunities, and threats. The research report includes global market numbers as well as regional market and segment figures. The analysts evaluated the categories using a top-down and bottom-up approachโ€ฆ
LED Dancing Floors Market Top Key Players and Driving Factors for Growth from 2023 to 2030 | LIGMAN, Ansell Lighting, Cascade Lighting, Collingwood Lighting
LED Dancing Floors Market Top Key Players and Driving Factors for Growth from 20 โ€ฆ
The Factual Market Research offers the [2023-2030] LED Dancing Floors contains a SWOT analysis and a Porter's five forces analysis, which aid in determining the market's precise path. These market measurement methods aid in the identification of market drivers, restraints, weaknesses, market opportunities, and threats. The research report includes global market numbers as well as regional market and segment figures. The analysts evaluated the categories using a top-down and bottom-upโ€ฆ
Effective Strategic Report on Bluetooth Smart Plugs Market In-Depth Insights In New Research Report 2023-2030 | Top Players: Belkin International, Etekcity, EDIMAX Technology, Insteon
Effective Strategic Report on Bluetooth Smart Plugs Market In-Depth Insights In โ€ฆ
The Factual Market Research offers the [2023-2030] Bluetooth Smart Plugs contains a SWOT analysis and a Porter's five forces analysis, which aid in determining the market's precise path. These market measurement methods aid in the identification of market drivers, restraints, weaknesses, market opportunities, and threats. The research report includes global market numbers as well as regional market and segment figures. The analysts evaluated the categories using a top-down and bottom-upโ€ฆ

All 5 Releases


More Releases for Trial

Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems โ€ฆ
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025? The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, withโ€ฆ
Transformative Trends Impacting the Electronic Trial Master File (eTMF) Systems โ€ฆ
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Electronic Trial Master File (eTMF) Systems Market Size By 2025? The market size of the electronic trial master file (eTMF) systems has experienced fast growth over recent years. The market is projected to increase from $1.36 billion in 2024 to $1.55 billion in 2025, withโ€ฆ
Clinical Trial Imaging market
The Clinical Trial Imaging market crossed the US$ 1.09 billion mark in 2022 and is expected to hit US$ 1.94 billion by 2030, recording a CAGR of 7.5% during the forecast period. Rising R&D spending, a rapidly growing pharmaceutical industry, and an increase in the number of contract research organizations are some of the major factors driving the market's growth. There has been an increase in pharmaceutical companies due to theโ€ฆ
Clinical Trial Management System
According to a new market report published by Persistence Market Research โ€œGlobal Market Study on Clinical Trial Management System: Asia to Witness Highest Growth by 2019โ€ the global clinical trial management system market was valued at USD 844.0 million in 2013 and is expected to grow at a CAGR of 14% from 2014 to 2019, to reach an estimated value of USD 1,848.5 million in 2019. Request Report TOC @ https://www.persistencemarketresearch.com/methodology/3017 โ€ฆ
Clinical Trial Logistics
Clinical Trial Logistics 16th to 17th May 2011, Marriott Regents Park, London, United Kingdom. It currently costs just over ยฃ500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinical trialsโ€ฆ
Clinical Trial Logistics
Announcing SMi's 5th annualโ€ฆ Clinical Trial Logistics conference 16th and 17th May 2011, Central London, UK www.smi-online.co.uk/2011logistics-london6.asp It currently costs just over ยฃ500 million ($800 million) to bring a new chemical to market and development timelines continue to fall in the 10-15 year range. A key reason for high R&D costs is due to logistical failures including failure to recruit patients on time. A way to avoid this is to move clinicalโ€ฆ